Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study

被引:0
|
作者
Yaodan Bi
Yinchao Zhu
Shuai Tang
Yuguang Huang
机构
[1] Peking Union Medical College Hospital,Department of Anesthesiology, Peking Union Medical College and Chinese Academy of Medical Sciences
[2] West China Hospital,Department of Anesthesiology
[3] Sichuan University,undefined
关键词
Migraine; Lipids; Drug target Mendelian randomization;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] HDL function as a target of lipid-modifying therapy
    Watson, Karol E.
    Ansell, Benjamin J.
    Watson, Andrew D.
    Fonarow, Gregg C.
    [J]. REVIEWS IN CARDIOVASCULAR MEDICINE, 2007, 8 (01) : 1 - 8
  • [22] Mendelian randomization study of lipid metabolism characteristics and migraine risk
    Hong, Peiwei
    Han, Lin
    Wan, Yang
    [J]. EUROPEAN JOURNAL OF PAIN, 2024, 28 (06) : 978 - 986
  • [23] The Association of Redox Regulatory Drug Target Genes with Psychiatric Disorders: A Mendelian Randomization Study
    Lu, Zhe
    Yang, Yang
    Zhao, Guorui
    Zhang, Yuyanan
    Sun, Yaoyao
    Liao, Yundan
    Kang, Zhewei
    Feng, Xiaoyang
    Sun, Junyuan
    Yue, Weihua
    [J]. ANTIOXIDANTS, 2024, 13 (04)
  • [24] Association of Antidiabetic Drug Target Genes with Inflammatory Bowel Disease: A Mendelian Randomization Study
    Qing, Xiangli
    Wang, Lin
    Fang, Shuangshuang
    Ban, Yanran
    Zhong, Zhuotai
    Sun, Weiqi
    Zhang, Chenhui
    Zhang, Tao
    Yang, Yang
    Wei, Wei
    [J]. JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 1389 - 1396
  • [25] Nicotinic acid as a lipid-modifying drug - A review
    Julius, U.
    Fischer, S.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2013, 14 (01) : 7 - 13
  • [26] Effects of blood lipids and lipid-modifying drugs on intracranial aneurysms
    Zhang, Baorui
    Dong, Siyuan
    Miao, Yan
    Song, Guangrong
    Yuan, Fei
    Liu, Lang
    Xia, Saide
    Qin, Yongkai
    Huo, Xiaochuan
    Wu, Zhongxue
    Miao, Zhongrong
    Mo, Dapeng
    Liu, Aihua
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (10) : 2967 - 2975
  • [27] Lipids, lipases, and lipid-modifying enzymes in plant disease resistance
    Shah, J
    [J]. ANNUAL REVIEW OF PHYTOPATHOLOGY, 2005, 43 : 229 - 260
  • [28] EFFECTS OF LIPID-LOWERING DRUGS ON IMPROVING KIDNEY FUNCTION: A DRUG TARGET MENDELIAN RANDOMIZATION STUDY
    Bennett, Schyler
    Walker, Venexia
    Zheng, Jie
    Brumpton, Ben
    Hveem, Kristian
    Kottgen, Anna
    Asvald, Bjorn
    Gaunt, Tom
    Rasheed, Humaira
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I663 - I664
  • [29] Effects of lipid-lowering drugs on improving kidney function: A drug target Mendelian randomization study
    Bennett, Schyler
    Walker, Venexia
    Zheng, Jie
    Brumpton, Ben
    Hveem, Kristian
    Kottgen, Anna
    Asvold, Bjorn Olav
    Gaunt, Tom
    Rasheed, Humaira
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 383 - 384
  • [30] Lipids, lipid-lowering drugs and lateral epicondylitis of the humerus: a drug-targeted Mendelian randomization study
    Liu, Meng-Meng
    Chen, Xiang
    Bao, Xiao-Hang
    Huang, Bao-Hua
    [J]. FRONTIERS IN GENETICS, 2024, 15